Clinical trial
Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic…
NCT00002470 · Mid-Atlantic Oncology Program, Other · Completed
Key facts
| NCT number | NCT00002470 |
|---|---|
| Title | Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors |
| Official title | A Phase II Study of Protracted Infusional 5-Fluorouracil Plus Alpha Interferon for Advanced Metastatic Carcinoid |
| Lead sponsor | Mid-Atlantic Oncology Program, Other |
| Collaborators | Cancer Biotherapy Research Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Gastrointestinal Carcinoid Tumor, Lung Cancer |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa, fluorouracil |
| Start date | Sep 1, 1990 |
| Completion | Jan 1, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | May 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: